Skip to main content
Download PDF

Antitumor activity and macrophage nitric oxide producing action of medicinal herb, Crassocephalum crepidioides

BMC Complementary and Alternative Medicine volume 12, Article number: 78 (2012) Cite this article

Abstract

Background

Crassocephalum crepidioides, a plant distributed in Okinawa Islands, is known in folk medicine; however, its anticancer activity has not been investigated. The aim of this study was to determine the in vitro and in vivo antitumor activities of C. crepidioides on murine Sarcoma 180 (S-180) and related molecular mechanisms.

Methods

The antitumor effect of C. crepidioides was evaluated in S-180-cell-bearing mice. Cell growth was assessed using a colorimetric assay. Nitrite and nitrate levels were measured by colorimetry. The expression levels of inducible NO synthase (iNOS) in murine RAW264.7 macrophages was assessed by reverse transcriptase-polymerase chain reaction. Activation of iNOS promoter was detected by reporter gene. Activation of nuclear factor-κB (NF-κB) was evaluated by electrophoretic mobility shift assay. The role of NF-κB signaling was analyzed using inhibitors of NF-κB and dominant-negative mutants, and Western blot analysis.

Results

C. crepidioides extract delayed tumor growth in S-180-bearing mice. However, it did not inhibit S-180 cell growth in vitro. Supernatant of cultured C. crepidioides-stimulated RAW264.7 macrophages was cytotoxic to S-180 cells. This cytotoxicity was associated with nitric oxide (NO) production. NF-κB signaling pathway was crucial for the transcriptional activation of iNOS gene. Isochlorogenic acid, a component of C. crepidioides, induced NF-κB activation and iNOS expression.

Conclusions

The results highlight the oncolytic and immunopotentiation properties of C. crepidioides mediated through NF-κB-induced release of NO from macrophages.

Peer Review reports

Background

Plants contain several classes of phytochemicals that have antioxidative, antimutagenic and anticarcinogenic effects. The edible plant, Crassocephalum crepidioides S. MOORE (Japanese name; Benibanaborogiku), is wildly distributed in the Okinawa Islands and used in folk medicine for the treatment of acute hepatitis, fever and edema. Compounds with antimalarial activity and strong antimutagenicity had been isolated previously from C. crepidioides[1, 2]. Other preparations from C. crepidioides have been described to have antioxidant and hepatoprotective properties [3]. However, the anticancer activity of C. crepidioides has not been investigated.

This is the first study that examines the antitumor effects of C. crepidioides extract. Although this extract is effective in inhibiting the in vivo growth of implanted Sarcoma-180 (S-180) cells, it did not inhibit the growth of the same cells in vitro. Activation of macrophages by agents such as bacterial lipopolysaccharide (LPS) stimulates their growth inhibitory effects against a wide variety of tumor cells [4]. In the present study, we report that C. crepidioides extract can induce the production of nitric oxide (NO), a major mediator of the tumoricidal activity of murine macrophages. In addition, serum nitrite and nitrate levels were significantly elevated in mice administered C. crepidioides extract compared with levels in the control group. Specifically, we characterized the mechanisms of the actions of C. crepidioides extract on inducible NO synthase (iNOS) promoter in murine macrophages. The antitumor efficacy of the extract was based on immunopotentiation, mediated, at least in part, by isochlorogenic acid.

Methods

Reagents

Fresh C. crepidioides was harvested in Subtropical Field Science Center of the University of the Ryukyus, Okinawa, Japan, and air-dried. Dried C. crepidioides (50 g) was extracted twice with 500 ml of boiling water for 30 min and the supernatant was decanted. After filtration, the combined supernatants were evaporated in vacuum and finally lyophilized to the powder. The extract obtained was used as an original extract, and dissolved with pure water when necessary. Isochlorogenic acid was purified using the procedure described previously with some modifications [3]. The extract dissolved in pure water was applied to a HP-20 (Mitsubishi Chemical, Tokyo, Japan) column eluting water and increasing amount of methanol (MeOH) to yield 70% MeOH fraction. After passing the fraction through C18 Sep-Pak cartridge (Waters, Millford, MA, USA), the final purification of the fraction was carried out by a Toyopearl HW-40 C (Tosho, Tokyo, Japan) column with 50% MeOH as an eluent. The 50% MeOH fraction contained 94% of isochlorogenic acid by absorption at 320 nm, following separation by reversed phase HPLC on C18 column (Nomura Chemical, Seto, Japan). C. crepidioides was dissolved in Dulbecco’s modified Eagle’s medium to a final concentration of 20 mg/ml.

Antibodies to nuclear factor-κB (NF-κB) subunits p65, p50, c-Rel and p52 were purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Antibody to actin was purchased from NeoMarkers (Fremont, CA, USA). Antibodies to IκBα and phospho-IκBα (Ser32 and Ser36) were obtained from Cell Signaling Technology (Beverly, MA, USA). N-acetyl-L-leucyl-L-leucyl-L-norleucinal (LLnL) and Bay 11-7082 were purchased from Sigma-Aldrich (St Louis, MO, USA) and Calbiochem (La Jolla, CA, USA), respectively.

In vivo therapeutic effect of C. Crepidioides

Four-week-old female BALB/c strain athymic nu/nu mice were obtained from Ryukyu Biotec Co. (Urasoe, Japan). They were engrafted with 2 × 105 S-180 cells by subcutaneous injection in the back region. Treatment was initiated on the day of cell inoculation. C. crepidioides was dissolved in distilled water at a concentration of 333 mg/ml, and 5 g/kg body weight of C. crepidioides was administered by oral gavage every day for 29 days. Tumor size was monitored once a week. All mice were sacrificed on day 28 and the tumors dissected out immediately. Tumors were fixed for paraffin embedding and tissue sectioning, and evaluated histologically using hematoxylin and eosin (H&E). This experiment was performed according to the guidelines for Animal Experimentation of the University of the Ryukyus and approved by the Animal Care and Use Committee of the same University.

Cells

The mouse sarcoma cell line S-180 and macrophage cell line RAW264.7 were cultured in Eagle’s Minimum Essential Medium and Dulbecco’s modified Eagle’s medium supplemented with 10% heat-inactivated fetal bovine serum, respectively.

Assays for cell growth

S-180 and RAW264.7 cells were seeded on 96-well plates and cultured for 24 h. C. crepidioides was added at various concentrations and incubated for 24, 48 and 72 h. In addition, the culture media were removed and replaced by supernatants from C. crepidioides-stimulated RAW264.7 cells. The growth of cells was evaluated by measuring the mitochondrial-dependent conversion of the water-soluble tetrazolium (WST)-8 (Nacalai Tesque, Kyoto, Japan) to a colored formazan product [5]. After 24, 48 and 72 h of culture, WST-8 (5 μl) was added to each well containing cultured cells in the last 4 h of incubation. Absorbance at 450 nm was measured using an automated microplate reader. The cell growth in untreated control cultures was considered 100%, and the growth of each treated group was compared relative to this value.

Measurement of NO

Nitrite (NO2 −), the stable end product of NO was measured in the supernatants by the colorimetric assay. Briefly, the medium was removed from individual wells and treated with Griess reagent (1% sulphanilamide and 0.1% naphtylethylene diamine dihydrochloride in 2% H3PO4) for 10 min at room temperature. The optical density of the samples was obtained using an automated microplate reader at 550 nm. A standard curve using a standard solution of NaNO2 in culture medium was employed to calculate the nitrite concentration. The levels of nitrite (NO2 −) and nitrate (NO3 −) anions derived from NO in murine sera were measured by an ENO-20 NO analyzer (EiCOM, Kyoto, Japan).

Western blot analysis

Cells were lysed and equal amounts of protein (20 μg) were subjected to electrophoresis on sodium dodecyl sulphate-polyacrylamide gels followed by transfer onto a polyvinylidene difluoride membrane and probing with the specific antibodies. The bands were visualized with an enhanced chemiluminescence kit (Amersham Biosciences, Piscataway, NJ, USA). The reported results were obtained from at least two independent experiments with a similar pattern.

Reverse transcriptase-polymerase chain reaction (RT-PCR)

Total cellular RNA was extracted with TRIzol (Invitrogen, Carlsbad, CA, USA). First-strand cDNA was synthesized from 1 μg total cellular RNA using an RNA-PCR kit (Takara Bio Inc., Otsu, Japan) with random primers. The primers used were 5’-TCATTGTACTCTGAGGGCTGACACA-3’ (forward) and 5’-GCCTTCAACACCAAGGTTGTCTGCA-3’ (reverse) for murine iNOS, and 5’-GTGGGGCGCCCCAGGCACCA-3’ (forward) and 5’-CTCCTTAATGTCACGCACGATTTC-3’ (reverse) or β-actin. The length of RT-PCR was 25 cycles for iNOS and 28 cycles for β-actin. The PCR products were fractionated on 2% agarose gels and visualized by ethidium bromide staining.

Transfection and luciferase assay

The IκBαΔN- and IκBβΔN-dominant-negative mutants are IκBα and IκBβ deletion mutants lacking the N-terminal 36 and 23 amino acids, respectively [6, 7]. The dominant-negative mutants of IκB kinase (IKK)α, IKKα (K44M), IKKβ, IKKβ (K44A), IKKγ, IKKγ (1-305) and NF-κB-inducing kinase (NIK), NIK (KK429/430AA) have been described previously [8, 9]. pGL3 iNOS plasmid was generated by inserting the murine iNOS promoter region (−1588 to +161 bp surrounding the transcription start site) into the pGL3-basic vector (Promega, Madison, WI, USA) [10]. Three internal deletion mutants, pGL3 iNOS κB2−, pGL3 iNOS κB1− and pGL3 iNOS κB1/κB2−, were constructed by deletion of two NF-κB sites defined as the κB1 (−85 to −76) and κB2 (−971 to −962). For reporter assays, an NF-κB site-dependent luciferase vector, κB-LUC [11] was also used. RAW264.7 cells were plated and transfected with the appropriate reporter and effector plasmids using Lipofectamine reagent (Invitrogen). After 18-20 h, C. crepidioides was added and incubated for 6 h. The cells were lysed in reporter lysis buffer (Promega). Lysates were assayed for reporter gene activity with the dual-luciferase assay system (Promega). Luciferase activities were normalized relative to the Renilla luciferase activity from phRL-TK.

Electrophoretic mobility shift assay (EMSA)

Nuclear extracts were obtained as described by Antalis and Godbolt [12] with modifications, and EMSA was performed as described previously [13]. The probes used were prepared by annealing the sense and antisense synthetic oligonucleotides; a κB1 site from the murine iNOS gene (5’-tcgaCCAACTGGGGACTCTCC CTTTGGGAA-3’), a κB2 site from the murine iNOS gene (5’-tcgaTGCTAGGGGGATTTTCC CTCTCTCTG-3’) and an AP-1 element of the interleukin (IL)-8 gene (5’-gatcGTGATGACTCA GGTT-3’). The above underlined sequences represent the NF-κB or AP-1 binding site. The reported results were obtained from at least two independent experiments with a similar pattern.

Statistical analysis

Data are expressed as mean ± SD. Differences between groups were assessed for statistical significance by the Mann-Whitney’s U-test. A P value < 0.05 denoted the presence of a statistically significant difference.

Results

Effects of C. Crepidioides in nude mice inoculated with S-180 cells

To explore the effect of C. crepidioides on tumor growth in nude mice transplanted with murine S-180, we treated tumor-bearing mice with 5 g/kg of C. crepidioides extract. The mean tumor volume was significantly lower than that of control mice after 14-day treatment (P = 0.0433, Figure 1A). However, the difference in tumor volume after 21- and 27-days treatment, compared with control, was less conspicuous. There was no significant difference in body weight gain from day 0 to day 28 between the control and C. crepidioides-treated groups (data not shown), and mice treated with C. crepidioides appeared generally healthy during the same period. On the other hand, treatment of S-180 cells with C. crepidioides for 29 days produced strong H&E staining for apoptosis (Figure 1B). These results suggest that C. crepidioides has antitumor in vivo effect.

Figure 1
figure1

In vivo and in vitro antitumor activities of C. crepidioides on S-180 cells. (A) Inhibition of growth of S-180 cells in nude mice. Growth of the tumors after subcutaneous inoculation of S-180 cells. Note the growth-suppressive effect of C. crepidioides. Data are mean ± SD of four mice in each group. The P values are the results of statistical analysis of the C. crepidioides and control data. (B) H&E-stained tissues demonstrating the pathological changes induced by treatment with C. crepidioides. Magnification, ×1000. (C) C. crepidioides does not have any antitumor activity on S-180 cells by itself. S-180 cells were cultured with the indicated concentrations of C. crepidioides extract for 24, 48 or 72 h, and cell growth was determined in triplicate cultures by WST-8 assay. (D) Cytotoxic effect of C. crepidioides on RAW264.7 cells. The cell growth was determined in triplicate cultures by WST-8 assay. Cell growth in untreated control cultures was considered 100%. Data are mean ± SD of triplicate cultures expressed as percentage of the control.

Full size image

Supernatant from C. crepidioides -stimulated RAW264.7 cells but not C. crepidioides alone causes cell growth inhibition of S-180 cells

To study the mechanism of the antitumor effect of C. crepidioides, we determined the effects of C. crepidioides on cell growth of S-180 cells in vitro. Cell growth was assessed by the WST-8 assay. Incubation with C. crepidioides alone at concentrations up to 500 μg/ml for 72 h did not affect cell growth (Figure 1C). Activation of macrophages by agents such as bacterial LPS stimulates their growth inhibitory effects on a wide variety of tumor cells [4]. Based on this property, we investigated the effects of macrophages on S-180 cells. RAW264.7 cells were incubated with various concentrations of C. crepidioides. C. crepidioides did not have any growth inhibitory activity on RAW264.7 cells at concentrations up to 500 μg/ml for 24 h, but a mild inhibitory effect was noted at 500 μg/ml and incubation for 48 and 72 h (Figure 1D).

S-180 cells were also cultured with supernatants from RAW264.7 cells that had been stimulated by various concentrations of C. crepidioides for 72 h. The supernatants suppressed cell growth of S-180 cells in a C. crepidioides dose-dependent manner (Figure 2A), while C. crepidioides-containing control medium had no growth inhibitory activity on S-180 cells, similar to the data shown in Figure 1C (Figure 2B).

Figure 2
figure2

Antitumor effect of supernatants from C. crepidioides -stimulated RAW264.7 cells on S-180 cells and effects of C. crepidioides on NO production in RAW264.7 cells. (A, B) Antitumor effects of supernatants from C. crepidioides-stimulated RAW264.7 cells against S-180 cells, measured by WST-8 assay. RAW264.7 cells were cultured with various concentrations of C. crepidioides extract for 72 h. The control samples did not include RAW264.7 cells. At the end of each incubation period, the supernatant was collected. S-180 cells were precultured for 24 h. Thereafter, the culture media were removed and replaced with supernatants from C. crepidioides-stimulated RAW264.7 cells (A) or by the control medium (B). S-180 cells were incubated for another 24, 48 or 72 h, and cell growth was determined in triplicate cultures by WST-8 assay. Cell growth in control cultures (supernatants from unstimulated RAW264.7 cells (A) or control medium in the absence of C. crepidioides (B)) was considered 100%. Data are mean ± SD values expressed as percentage of the control. (C, D) Effects of C. crepidioides on NO production in RAW264.7 cells. RAW264.7 cells were incubated with or without C. crepidioides (500 μg/ml) (C) or with various concentrations of C. crepidioides (D) for the indicated time periods. NO production was determined by measuring the accumulation of nitrite in the culture medium. Data are mean ± SD of triplicate cultures.

Full size image

C. Crepidioides induces NO production and expression of iNOS mRNA

Previous studies demonstrated the crucial role of NO in the tumoricidal activity of murine macrophages [14–16]. The addition of exogenous NO donor, NOR3, to the culture medium of S-180 cells inhibited cell growth (data not shown). Therefore, we examined the effects of C. crepidioides on NO production by RAW264.7 cells in vitro. NO production by stimulated RAW264.7 cells was assessed by measuring nitrite in the culture medium. C. crepidioides stimulated the production of nitrite from RAW264.7 cells in time- and dose-dependent manners (Figure 2C and D). In in vivo experiments, mice orally administered C. crepidioides had significantly high serum nitrite and nitrate levels compared with the control (Figure 3).

Figure 3
figure3

Effect of oral administration of C. crepidioides (5 g/kg) on serum levels of nitrite (NO 2 − ) and nitrate (NO 3 − ). (A-C) Serum levels of nitrite (A), nitrate (B) and nitrite plus nitrate (C, D) in C. crepidioides-treated and untreated mice at day 28. (D) Data are mean ± SD of four mice in each group.

Full size image

What is the mechanism of C. crepidioides-stimulated NO production? NO is synthesized by NOS-catalyzed conversion of L-arginine to L-citrulline. Whereas the activity of neuronal and endothelial NOS is mainly regulated post-translationally by cytoplasmic calcium levels or by phosphorylation by various protein kinases, iNOS is primarily regulated at the transcriptional level [17]. Next, we determined whether C. crepidioides-induced NO production from RAW264.7 cells was catalyzed by iNOS. The addition of 500 μg/ml C. crepidioides to RAW264.7 cells resulted in the expression of iNOS mRNA from 1 h after treatment (Figure 4A). In another setting, incubation with C. crepidioides for 3 h at 15.6 μg/ml induced iNOS mRNA expression in RAW264.7 cells (Figure 4B). The main antioxidant isolated from C. crepidioides is isochlorogenic acid [3]. Isochlorogenic acid stimulated iNOS expression in a manner similar to that by C. crepidioides (Figure 4C and D). These results suggest that the C. crepidioides-induced increase in NO production by RAW264.7 cells is mediated by the induction of iNOS expression, and that isochlorogenic acid seems to contribute to at least part to this augmented production of NO.

Figure 4
figure4

Effects of C. crepidioides and isochlorogenic acid on the expression of iNOS mRNA in RAW264.7 cells. (A, C) RAW264.7 cells were incubated with C. crepidioides (500 μg/ml) (A) or isochlorogenic acid (500 μg/ml) (C) for the indicated time periods. (B, D) RAW264.7 cells were cultured with various concentrations of C. crepidioides (B) or isochlorogenic acid (D) for 3 h. iNOS mRNA expression was detected by RT-PCR.

Full size image

NF-κB sites are necessary for C. Crepidioides inducibility of iNOS promoter

To assess the effect of C. crepidioides on iNOS promoter activity, RAW264.7 cells were transfected with a murine iNOS-luciferase promoter/reporter construct and then incubated with various concentrations of C. crepidioides. The cells were lysed, and luciferase activity was measured. C. crepidioides increased the expression of luciferase from the iNOS promoter in a dose-dependent manner (Figure 5A). The expression of the iNOS gene in macrophages is regulated mainly at the transcriptional level, particularly by NF-κB [18–21]. The murine iNOS promoter contains two putative NF-κB binding sites, one upstream (GGGATTTTCC, −971 to −962 bp, designated NF-κB2) and one downstream (GGGACTCTCC, −85 to −76 bp, designated NF-κB1). To test the relative contribution of the NF-κB binding sites to the C. crepidioides-mediated activation of iNOS, we introduced a deletion into each or both sites. A single deletion of the κB2 site markedly inhibited C. crepidioides-mediated promoter activation, whereas a single deletion of the κB1 site resulted in moderate activation. On the other hand, double deletion completely abolished the C. crepidioides-mediated promoter activation (Figure 5B).

Figure 5
figure5

NF- κB sites in murine iNOS promoter are essential for C. crepidioides responsiveness. (A) RAW264.7 cells were transfected with a murine iNOS promoter construct (pGL3 iNOS) or pGL3-basic, and then treated with the indicated concentrations of C. crepidioides for 6 h and lysed for luciferase activity analysis. All values were calculated as change (n-fold) in induction values relative to the basal level measured in untreated cells. (B) RAW264.7 cells were transfected with the indicated luciferase reporter plasmids. After transfection, the cells were left untreated or treated with C. crepidioides (250 and 500 μg/ml) for 6 h, and luciferase activity was measured. The activities are expressed relative to that of cells transfected with pGL3 iNOS without further treatment, which was defined as 1. Luciferase activity was normalized relative to the Renilla luciferase activity from phRL-TK. LUC, luciferase. Data are mean ± SD of three independent experiments.

Full size image

C. Crepidioides induces binding of NF-κB family proteins to two NF-κB sites

We next characterized the nuclear proteins in C. crepidioides-treated RAW264.7 cells that bind to sequences from the iNOS promoter in an NF-κB-dependent manner. EMSA was performed using two probes; miNOS κB1 and κB2, oligonucleotides consisting of the NF-κB1 and NF-κB2 elements. C. crepidioides induced a time-dependent appearance of nuclear proteins that bound to both probes in RAW264.7 cells (Figure 6A). In both probes, the addition of excess unlabeled κB1 and κB2 oligonucleotides to the binding reaction completely abolished the formation of inducible DNA-protein complexes (Figure 6B, lanes 2 and 9). In contrast, the formation of these DNA-protein complexes was not blocked by the addition of excess of unrelated oligonucleotide AP-1 (Figure 6B, lanes 3 and 10). To identify the NF-κB family members that bind to the NF-κB motifs of the murine iNOS gene promoter, the binding reactions were preincubated with antibodies specific to p50, p65, c-Rel and p52. The anti-p50 and anti-p65 antibodies induced the supershifted bands and reduced the intensity of complexes κB1 and κB2 (Figure 6B, lanes 4, 5, 11 and 12). The c-Rel antibody also supershifted complexes κB1 and κB2 (Figure 6B, lanes 6 and 13). These results indicate that the complexes κB1 and κB2 correspond to p50/p65/c-Rel.

Figure 6
figure6

Effects of C. crepidioides on signal pathway through NF- κB activation. (A) NF-κB1- and NF-κB2-dependent binding of nuclear proteins in RAW264.7 cells. The cells were treated with C. crepidioides (500 μg/ml) for the indicated time periods before preparing nuclear extracts for analysis by EMSA with probe miNOS κB1 or κB2. (B) Sequence specificity of NF-κB binding activity and characterization of proteins that bound to the NF-κB binding sites. Competition assays were performed with nuclear extracts from cells treated with C. crepidioides (500 μg/ml) for 2 h. Excess amounts of competitor (100-fold) were added (lanes 2, 3, 9 and 10). Supershift assay in the same nuclear extracts was also performed. Antibodies (Ab) were added (lanes 4-7 and 11-14). Arrows: specific complexes, arrowheads: supershifted DNA binding complexes. (C) C. crepidioides induces phosphorylation and degradation of IκBα. Cells were treated with C. crepidioides (500 μg/ml) for the indicated time periods and lysates were subjected to immunoblotting. (D) Overexpression of dominant-negative mutants inhibits C. crepidioides-induced activation of the iNOS promoter. Cells were transfected with pGL3 iNOS or κB-LUC and the mutant plasmids and then treated with C. crepidioides (500 μg/ml) for 6 h. Open bar: luciferase activity of pGL3 iNOS and empty vector or κB-LUC alone without treatment. All values were calculated as the change (n-fold) in induction value relative to the basal level measured in untreated cells. LUC, luciferase. Data are mean ± SD of three independent experiments.

Full size image

NF-κB signal is essential for C. Crepidioides-induced iNOS expression

Does C. crepidioides-mediated upregulation of iNOS gene expression involve signal transduction components in NF-κB activation? Activation of NF-κB requires the phosphorylation of two conserved serine residues of NF-κB inhibitory subunit, IκBα (Ser32 and Ser36) within the N-terminal domain [22]. Phosphorylation leads to the ubiquitination and 26 S proteasome-mediated degradation of IκBα, thereby releasing NF-κB from the complex and its translocation to the nucleus and activation of various genes [22]. Next, we determined the role of IκBα phosphorylation and degradation in C. crepidioides-induced NF-κB translocation and activation by Western blot analysis using antibodies against phosphorylated and total IκBα. Treatment of RAW264.7 cells with C. crepidioides resulted in phosphorylation and degradation of IκBα within 30 min (Figure 6C).

Next, RAW264.7 cells were transfected with the luciferase reporter plasmid regulated by NF-κB elements (κB-LUC; [11]) and then incubated with C. crepidioides (Figure 6D). The results showed that C. crepidioides induced NF-κB activation. To further confirm the involvement of IκBα phosphorylation and degradation, we transfected the cells with transdominant mutant of IκBα in which two critical serine residues required for inducer-mediated phosphorylation were deleted [6]. Overexpression of mutant IκBα inhibited the C. crepidioides-induced iNOS promoter activation (Figure 6D), suggesting the involvement of IκBα phosphorylation and degradation in C. crepidioides-induced iNOS expression.

IκBβ also contains an N-terminal regulatory region required for stimulus-induced degradation, a key step in NF-κB activation [22]. Overexpression of mutant IκBβ in which two critical serine residues required for inducer-mediated phosphorylation were deleted [7], also inhibited the C. crepidioides-induced iNOS promoter activation (Figure 6D). These results suggest the involvement of IκBβ phosphorylation and degradation in C. crepidioides-induced iNOS expression.

The IKK complex consists of two catalytic subunits IKKα and IKKβ, and the regulatory subunit IKKγ [22]. In the NF-κB activation pathway, IKK complex can induce serine phosphorylation of IκBα and IκBβ [22]. Previous studies suggested the involvement of serine/threonine kinase NIK in phosphorylation and activation of the IKK complex [23]. To determine the roles of NIK, IKKα, IKKβ and IKKγ in C. crepidioides-induced iNOS expression in RAW264.7 cells, plasmids encoding dominant-negative mutants of NIK, IKKα, IKKβ and IKKγ were used. As shown in Figure 6D, transfection with dominant–negative mutants of NIK, IKKα, IKKβ and IKKγ significantly attenuated C. crepidioides-induced iNOS expression. Taken together, these findings demonstrate that C. crepidioides induces iNOS expression via activation of NF-κB mediated through the NIK/IKK pathway.

Isochlorogenic acid activates NF-κB

To determine the role of active compounds on C. crepidioides-induced iNOS expression, we examined whether isochlorogenic acid activates NF-κB. Treatment of RAW264.7 cells with isochlorogenic acid resulted in phosphorylation of IκBα (Figure 7A) and induction of nuclear proteins that bound to both miNOS κB1 and κB2 probes (Figure 7B). These results suggest that isochlorogenic acid in C. crepidioides seems to contribute at least in part to the induction of iNOS expression through IκBα phosphorylation and subsequent NF-κB activation.

Figure 7
figure7

Effects of isochlorogenic acid on NF- κB activity. (A) Isochlorogenic acid induces phosphorylation of IκBα. Cells were treated with isochlorogenic acid (500 μg/ml) for the indicated time periods. Lysates were subjected to immunoblotting. (B) NF-κB1- and NF-κB2-dependent binding of nuclear proteins in RAW264.7 cells. The cells were treated with isochlorogenic acid (500 μg/ml) for the indicated time periods before preparing nuclear extracts for analysis by EMSA with probe miNOS κB1 or κB2.

Full size image

Effects of NF-κB inhibitors on C. Crepidioides-induced iNOS expression and NO production

Because activation of the iNOS promoter by C. crepidioides required the activation of NF-κB, we blocked NF-κB activation with Bay 11-7082, an inhibitor of IκBα phosphorylation [24] or LLnL, a proteasome inhibitor [25]. Bay 11-7082 and LLnL reduced C. crepidioides-induced iNOS promoter activity (Figure 8A). In addition, Bay 11-7082 and LLnL diminished C. crepidioides-induced iNOS mRNA expression and NO production in RAW264.7 cells (Figure 8B and C).

Figure 8
figure8

Effects of Bay 11-7082 and LLnL on C. crepidioides -induced iNOS expression and NO production in RAW264.7 cells. (A) iNOS reporter gene analysis. RAW264.7 cells were transfected with the indicated luciferase reporter plasmids. After transfection, the cells were incubated in a medium containing Bay 11-7082 (20 μM) or LLnL (20 μM) for 1 h and then treated with C. crepidioides (500 μg/ml) for 6 h. Thereafter, luciferase activities were measured. The activities are expressed relative to that of cells transfected with pGL3 iNOS without further treatment, which was defined as 1. LUC, luciferase. Data are mean ± SD of three independent experiments. (B) RAW264.7 cells were pretreated with Bay 11-7082 (20 μM) or LLnL (10 μM) for 1 h before stimulation with C. crepidioides (500 μg/ml) for another 6 h. The iNOS mRNA expression was determined by RT-PCR. (C) RAW264.7 cells were pretreated with the indicated concentrations of Bay 11-7082 or LLnL for 1 h before stimulation with the indicated concentrations of C. crepidioides for another 48 h. The nitrite content in the culture media was analyzed. Data are mean ± SD of triplicate cultures. C. c., C. crepidioides.

Full size image

Discussion

Alternative therapeutic tools obtained from plants to fight cancer have attracted great interest. This is the first study to report the antitumor effect of C. crepidioides extract in S-180 cell-bearing mice. The results demonstrated the effectiveness of C. crepidioides in inhibiting the growth of implanted S-180 cells, although this effect was not mirrored in the in vitro studies. Activated macrophages are important in host defense against tumors, including tumor cytotoxicity. NO appears to be a major mediator of macrophage tumoricidal activity [14–16]. NO secreted by activated macrophages inactivates iron-containing enzymes critical to the viability of tumor cells [26]. The present study was designed to determine whether C. crepidioides extract activated macrophages to the tumoricidal phenotype.

The results demonstrated that C. crepidioides extract alone did not inhibit S-180 cell growth in vitro. However, the supernatant from C. crepidioides-treated RAW264.7 cells inhibited S-180 cell growth. This antitumor activity was associated with NO production in activated RAW264.7 cells, and administration of C. crepidioides in mice induced a significant increase in serum nitrite and nitrate levels. Thus, NO seems a significant component of the pathway responsible for tumor regression. In this context, it should be emphasized that this experimental approach only allows the study of the effects mediated by soluble mediators. Other interactions involving direct contact between S-180 cells and neighboring macrophages will have additional effects on S-180 cells, modulating the proliferation and apoptosis of S-180 cells.

Another part of the present study investigated the molecular mechanism of C. crepidioides-induced NO production. NO formation is catalyzed by iNOS from L-arginine. Macrophage iNOS is not expressed in resting cells and differs from the constitutive neuronal and endothelial NOS [17]. Extensive studies of the transcriptional control of iNOS expression in murine macrophages have stressed the importance of binding of NF-κB [18–21], IRF-1 [27], Stat1 [28] and Oct-1 [29, 30] to their recognition sequences on the iNOS promoter region for activation of iNOS transcription by interferon γ, LPS, IL-6 and Taxol. We showed here that C. crepidioides rapidly activated NF-κB. Moreover, we confirmed the essential role of NF-κB in C. crepidioides-induced iNOS promoter activity using deletion mutant forms of the two NF-κB recognition sites in the iNOS promoter, termed NF-κB1 and NF-κB2. Nuclear protein complexes that bind specifically to NF-κB1 and NF-κB2 after treatment of RAW264.7 cells with C. crepidioides contained p50/p65/c-Rel. The components of the NF-κB complexes formed in response to LPS consisted primarily of p50, with very low levels of p65 and c-Rel subunits [18, 21]. These results support the view that LPS and C. crepidioides extract activate NF-κB through the same signaling pathway. Because various phytochemicals have been shown to suppress LPS-induced iNOS expression [31], we examined the effects of C. crepidioides extract on LPS-induced iNOS mRNA expression and NO production. However, C. crepidioides failed to suppress both events induced by LPS (data not shown).

Bay 11-7082 and LLnL are relatively specific inhibitors of NF-κB activation [24, 25]. Both agents blocked the promoter activity of iNOS, the expression of iNOS mRNA, and the production of nitrite, indicating the likely involvement of NF-κB in the induction of not just iNOS-driven reporter constructs but also the iNOS gene itself in C. crepidioides-treated macrophages. We also confirmed the important role of NF-κB and the upstream target of C. crepidioides by showing that overexpression of dominant-negative potent inhibitors of NF-κB activation (NIK, IKKs and IκBs) inhibited C. crepidioides-induced activation of iNOS promoter.

Compounds with antioxidant activities have been isolated previously from C. crepidioides[3], including isochlorogenic acid and the flavonoids quercetin and kaempferol. However, the latter two have anti-inflammatory properties and are known to inhibit LPS-induced iNOS expression and NO production [32, 33]. For this reason, isochlorogenic acid was selected in this study. Results indicated that isochlorogenic acid induces NF-κB activation and subsequent iNOS induction, and thus contributes, at least in part, to the tumoricidal effects of C. crepidioides.

Considered together, our results indicated that C. crepidioides causes regression of murine S-180 tumor and that this effect is mediated by activated macrophages through NO production. These results suggest that C. crepidioides is an interesting plant for the development of novel anticancer agents. However, further studies are needed to determine the effects of C. crepidioides extract and isochlorogenic acid on tumor growth in patients with malignant tumors.

Conclusions

We reported in the present study the suppressive effects of C. crepidioides extract on tumor growth in S-180 model through the induction of NO production. Also, the extract stimulated macrophages and induced NO production via NF-κB signaling pathway. NO production may play an important role in the antitumor activity of C. crepidioides on S-180 cells. The results suggest that C. crepidioides is a potentially useful chemopreventive and chemotherapeutic agent, thus justifying further investigation of other possible beneficial biological properties.

References

  1. 1.

    Kongsaeree PK, Prabpai S, Sriubolmas N, Vongvein C, Wiyakrutta S: Antimalarial dihydroisocoumarins produced by Geotrichum sp., an endophytic fungus of Crassocephalum crepidioides. J Nat Prod. 2003, 66: 709-711. 10.1021/np0205598.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Yen GC, Chen HY, Peng HH: Evaluation of the cytotoxicity, mutagenicity and antimutagenicity of emerging edible plants. Food Chem Toxicol. 2001, 39: 1045-1053. 10.1016/S0278-6915(01)00053-9.

    CAS  Article  PubMed  Google Scholar 

  3. 3.

    Aniya Y, Koyama T, Miyagi C, Miyahira M, Inomata C, Kinoshita S, Ichiba T: Free radical scavenging and hepatoprotective actions of the medicinal herb, Crassocephalum crepidioides from the Okinawa Islands. Biol Pharm Bull. 2005, 28: 19-23. 10.1248/bpb.28.19.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Clancy RM, Abramson SB: Nitric oxide: a novel mediator of inflammation. Proc Soc Exp Biol Med. 1995, 210: 93-101.

    CAS  Article  PubMed  Google Scholar 

  5. 5.

    Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K: A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 1997, 44: 1299-1305. 10.1016/S0039-9140(97)00017-9.

    CAS  Article  PubMed  Google Scholar 

  6. 6.

    Brockman JA, Scherer DC, McKinsey TA, Hall SM, Qi X, Lee WY, Ballard DW: Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol Cell Biol. 1995, 15: 2809-2818.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  7. 7.

    McKinsey TA, Brockman JA, Scherer DC, Al-Murrani SW, Green PL, Ballard DW: Inactivation of IκBβ by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-κB. Mol Cell Biol. 1996, 16: 2083-2090.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Geleziunas R, Ferrell S, Lin X, Mu Y, Cunningham ET, Grant M, Connelly MA, Hambor JE, Marcu KB, Greene WC: Human T-cell leukemia virus type 1 Tax induction of NF-κB involves activation of the IκB kinase α (IKKα) and IKKβ cellular kinases. Mol Cell Biol. 1998, 18: 5157-5165.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  9. 9.

    Iha H, Kibler KV, Yedavalli VRK, Peloponese J-M, Haller K, Miyazato A, Kasai T, Jeang K-T: Segregation of NF-κB activation through NEMO/IKKγ by Tax and TNFα: implications for stimulus-specific interruption of oncogenic signaling. Oncogene. 2003, 22: 8912-8923. 10.1038/sj.onc.1207058.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Crosby MB, Svenson J, Gilkeson GS, Nowling TK: A novel PPAR response element in the murine iNOS promoter. Mol Immunol. 2005, 42: 1303-1310. 10.1016/j.molimm.2004.12.009.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Suzuki T, Hirai H, Murakami T, Yoshida M: Tax protein of HTLV-1 destabilizes the complexes of NF-κB and IκB-α and induces nuclear translocation of NF-κB for transcriptional activation. Oncogene. 1995, 10: 1199-1207.

    CAS  PubMed  Google Scholar 

  12. 12.

    Antalis TM, Godbolt D: Isolation of intact nuclei from hematopoietic cell types. Nucleic Acids Res. 1991, 19: 4301-10.1093/nar/19.15.4301.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Mori N, Prager D: Transactivation of the interleukin-1α promoter by human T-cell leukemia virus type I and type II Tax proteins. Blood. 1996, 87: 3410-3417.

    CAS  PubMed  Google Scholar 

  14. 14.

    Sveinbjørnsson B, Olsen R, Seternes OM, Seljelid R: Macrophage cytotoxicity against murine Meth A sarcoma involves nitric oxide-mediated apoptosis. Biochem Biophys Res Commun. 1996, 223: 643-649. 10.1006/bbrc.1996.0948.

    Article  PubMed  Google Scholar 

  15. 15.

    Hibbs JB, Taintor RR, Vavrin Z, Rachlin EM: Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem Biophys Res Commun. 1988, 157: 87-94. 10.1016/S0006-291X(88)80015-9.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Stuehr DJ, Nathan CF: Nitric oxide. A macrophage product responsible for cytostasis and respiratory inhibition in tumor target cells. J Exp Med. 1989, 169: 1543-1555. 10.1084/jem.169.5.1543.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Nathan C, Xie Q-W: Nitric oxide synthases: roles, tolls, and controls. Cell. 1994, 78: 915-918. 10.1016/0092-8674(94)90266-6.

    CAS  Article  PubMed  Google Scholar 

  18. 18.

    Xie Q-W, Kashiwabara Y, Nathan C: Role of transcription factor NF-κB/Rel in induction of nitric oxide synthase. J Biol Chem. 1994, 269: 4705-4708.

    CAS  PubMed  Google Scholar 

  19. 19.

    Lowenstein CJ, Alley EW, Raval P, Snowman AM, Snyder SH, Russell SW, Murphy WJ: Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon γ and lipopolysaccharide. Proc Natl Acad Sci USA. 1993, 90: 9730-9734. 10.1073/pnas.90.20.9730.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Goldring CEP, Narayanan R, Lagadec P, Jeannin J-F: Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-κB/Rel proteins. Biochem Biophys Res Commun. 1995, 209: 73-79. 10.1006/bbrc.1995.1472.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Kim YM, Paik S-G: Induction of expression of inducible nitric oxide synthase by Taxol in murine macrophage cells. Biochem Biophys Res Commun. 2005, 326: 410-416. 10.1016/j.bbrc.2004.11.043.

    CAS  Article  PubMed  Google Scholar 

  22. 22.

    Karin M, Ben-Neriah Y: Phosphorylation meets ubiquitination: the control of NF-κB activity. Annu Review Immunol. 2000, 18: 621-663. 10.1146/annurev.immunol.18.1.621.

    CAS  Article  Google Scholar 

  23. 23.

    Malinin NL, Boldin MP, Kovalenko AV, Wallach D: MAP3K-related kinase involved in NF-κB induction by TNF, CD95 and IL-1. Nature. 1997, 385: 540-544. 10.1038/385540a0.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Pierce JW, Schoenleber R, Jesmok G, Best J, Moore SA, Collins T, Gerritsen ME: Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo. J Biol Chem. 1997, 272: 21096-21103. 10.1074/jbc.272.34.21096.

    CAS  Article  PubMed  Google Scholar 

  25. 25.

    Jeremias I, Kupatt C, Baumann B, Herr I, Wirth T, Debatin KM: Inhibition of nuclear factor κB activation attenuates apoptosis resistance in lymphoid cells. Blood. 1998, 91: 4624-4631.

    CAS  PubMed  Google Scholar 

  26. 26.

    Lancaster JR, Hibbs JB: EPR demonstration of iron-nitrosyl complex formation by cytotoxic activated macrophages. Proc Natl Acad Sci USA. 1990, 87: 1223-1227. 10.1073/pnas.87.3.1223.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Martin E, Nathan C, Xie Q-W: Role of interferon regulatory factor 1 in induction of nitric oxide synthase. J Exp Med. 1994, 180: 977-984. 10.1084/jem.180.3.977.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Gao J, Morrison DC, Parmely TJ, Russell SW, Murphy WJ: An interferon-γ-activated site (GAS) is necessary for full expression of the mouse iNOS gene in response to interferon-γ and lipopolysaccharide. J Biol Chem. 1997, 272: 1226-1230. 10.1074/jbc.272.2.1226.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Sawada T, Falk LA, Rao P, Murphy WJ, Pluznik DH: IL-6 induction of protein-DNA complexes via a novel regulatory region of the inducible nitric oxide synthase gene promoter: role of octamer binding proteins. J Immunol. 1997, 158: 5267-5276.

    CAS  PubMed  Google Scholar 

  30. 30.

    Kim YM, Ko CB, Park YP, Kim YJ, Paik SG: Octamer motif is required for the NF-κB-mediated induction of the inducible nitric oxide synthase gene expression in RAW 264.7 macrophages. Mol Cells. 1999, 9: 99-109.

    CAS  PubMed  Google Scholar 

  31. 31.

    Murakami A, Ohigashi H: Targeting NOX, INOS and COX-2 in inflammatory cells: chemoprevention using food phytochemicals. Int J Cancer. 1999, 121: 2357-2363.

    Article  Google Scholar 

  32. 32.

    Ortega MG, Saragusti AC, Cabrera JL, Chiabrando GA: Quercetin tetraacetyl derivative inhibits LPS-induced nitric oxide synthase (iNOS) expression in J774A.1 cells. Arch Biochem Biophys. 2010, 498: 105-110. 10.1016/j.abb.2010.04.014.

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    Hämäläinen M, Nieminen R, Vuorela P, Heinonen M, Moilanen E: Anti-inflammatory effects of flavonoids: genistein, kaempferol, quercetin, and daidzein inhibit STAT-1 and NF-κB activations, whereas flavone, isorhamnetin, naringenin, and pelargonidin inhibit only NF-κB activation along with their inhibitory effect on iNOS expression and NO production in activated macrophages. Mediators Inflamm. 2007, 2007: 45673-

    Article  PubMed  PubMed Central  Google Scholar 

Pre-publication history

  1. The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1472-6882/12/78/prepub

Download references

Acknowledgements

We thank Drs. Kouji Wada and Yoko Aniya for the generous supply of C. crepidioides extract and isochlorogenic acid, and for assistance with the preparation of the manuscript. We acknowledge also Drs. Tamara K. Nowling, Dean W. Ballard, Romas Geleziunas and Kuan-Teh Jeang for providing pGL3 iNOS plasmid; for the expression vectors for IκBα- and IκBβ-dominant-negative mutants; for NIK-, IKKα- and IKKβ-dominant-negative mutants; and for IKKγ-dominant-negative mutant. We also thank Dr. Shigeki Sawada for conducting the pathological examination.

Author information

Affiliations

  1. Department of Microbiology and Oncology, Graduate School of Medicine, University of the Ryukyus, 207 Uehara, Nishihara, Okinawa, 903-0215, Japan

    Koh Tomimori, Shinji Nakama, Ryuichiro Kimura, Kazumi Tamaki, Chie Ishikawa & Naoki Mori

  2. Department of Psychiatry, Naha City Hospital, 2-31-1 Furujima Naha, Okinawa, 902-8511, Japan

    Koh Tomimori

  3. Musashino Research Institute for Immunity, 790 Nishizatozoe, Gusukube, Miyako Island, Okinawa, 906-0106, Japan

    Shinji Nakama

  4. Transdisciplinary Research Organization for Subtropics and Island Studies, 1 Senbaru Nishihara, Okinawa, 903-0213, Japan

    Ryuichiro Kimura & Chie Ishikawa

Authors
  1. Koh Tomimori
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shinji Nakama
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Ryuichiro Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kazumi Tamaki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Chie Ishikawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Naoki Mori
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Naoki Mori.

Additional information

Competing interests

The authors declare no conflict of interest.

Authors’ contributions

KTo designed and carried out the in vitro experiments. SN designed and carried out the in vivo experiments. RK carried out some RT-PCR experiments. KTa and CI made substantial contributions to the in vitro and in vivo experiments. NM conceived the idea, designed and coordinated the study and prepared the manuscript. All authors read and approved the final manuscript.

Authors’ original submitted files for images

Rights and permissions

Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Reprints and Permissions

About this article

Cite this article

Tomimori, K., Nakama, S., Kimura, R. et al. Antitumor activity and macrophage nitric oxide producing action of medicinal herb, Crassocephalum crepidioides . BMC Complement Altern Med 12, 78 (2012). https://doi.org/10.1186/1472-6882-12-78

Download citation

Keywords

  • Nitric Oxide
  • Electrophoretic Mobility Shift Assay
  • iNOS Expression
  • iNOS mRNA
  • iNOS Gene

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us

\